Israel Englander Otonomy, Inc. Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.25 - $2.24 $35,990 - $322,474
143,962 Added 759.57%
162,915 $48,000
Q2 2022

Aug 15, 2022
SELL
$1.72 - $2.51 $760 - $1,109
-442 Reduced 2.28%
18,953 $39,000
Q1 2022

May 16, 2022
BUY
$1.72 - $2.47 $1,049 - $1,506
610 Added 3.25%
19,395 $47,000
Q4 2021

Feb 14, 2022
BUY
$1.69 - $2.31 $31,746 - $43,393
18,785 New
18,785 $39,000
Q3 2021

Nov 15, 2021
SELL
$1.22 - $2.2 $143,664 - $259,067
-117,758 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$2.06 - $2.67 $242,581 - $314,413
117,758 New
117,758 $263,000
Q1 2021

May 17, 2021
SELL
$2.49 - $6.23 $2.03 Million - $5.08 Million
-814,832 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$3.48 - $6.47 $991,657 - $1.84 Million
284,959 Added 53.78%
814,832 $5.27 Million
Q3 2020

Nov 16, 2020
SELL
$3.16 - $4.36 $424,678 - $585,949
-134,392 Reduced 20.23%
529,873 $2.15 Million
Q2 2020

Aug 14, 2020
BUY
$1.87 - $3.84 $545,929 - $1.12 Million
291,941 Added 78.41%
664,265 $2.41 Million
Q1 2020

May 14, 2020
BUY
$1.58 - $4.06 $92,360 - $237,331
58,456 Added 18.62%
372,324 $733,000
Q4 2019

Feb 14, 2020
BUY
$2.13 - $3.83 $629,953 - $1.13 Million
295,753 Added 1632.64%
313,868 $1.2 Million
Q3 2019

Nov 14, 2019
SELL
$2.12 - $2.86 $23,506 - $31,711
-11,088 Reduced 37.97%
18,115 $43,000
Q2 2019

Aug 15, 2019
BUY
$2.35 - $3.09 $33,889 - $44,560
14,421 Added 97.56%
29,203 $80,000
Q2 2019

Aug 14, 2019
SELL
$2.35 - $3.09 $142,811 - $187,782
-60,771 Reduced 80.43%
14,782 $385,000
Q1 2019

May 14, 2019
SELL
$1.8 - $2.97 $27,433 - $45,265
-15,241 Reduced 16.79%
75,553 $199,000
Q4 2018

Feb 14, 2019
SELL
$1.51 - $2.93 $489,096 - $949,041
-323,905 Reduced 78.11%
90,794 $168,000
Q3 2018

Nov 14, 2018
SELL
$2.6 - $3.95 $472,238 - $717,438
-181,630 Reduced 30.46%
414,699 $1.14 Million
Q2 2018

Aug 14, 2018
BUY
$3.7 - $4.75 $1.77 Million - $2.28 Million
479,271 Added 409.43%
596,329 $2.3 Million
Q1 2018

May 15, 2018
SELL
$4.05 - $6.1 $929,110 - $1.4 Million
-229,410 Reduced 66.21%
117,058 $492,000
Q4 2017

Feb 14, 2018
SELL
$2.8 - $5.55 $1.57 Million - $3.12 Million
-561,716 Reduced 61.85%
346,468 $1.92 Million
Q3 2017

Nov 14, 2017
BUY
$3.2 - $20.8 $2.91 Million - $18.9 Million
908,184
908,184 $2.95 Million

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email